Stockreport

Sage Therapeutics down 7% on Biogen/Ionis deal [Seeking Alpha]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF Sage Therapeutics down 7% on Biogen/Ionis dealSAGE Therapeutics (SAGE-7.4%) slumps on below-average volume. Investors apparently perceive diminished prospects for a deal [Read more]